Form 4: Equillium CEO Bruce D. Steel Acquires 410,000 Stock Options

Equillium's President and CEO, Bruce D. Steel, has acquired 410,000 employee stock options at an exercise price of $0.77.

Summary

• Bruce D. Steel, President and CEO of Equillium, Inc., has reported the acquisition of 410,000 employee stock options.
• The options have an exercise price of $0.77 per share.
• The options vest over a period of four years, with 25% vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments.
• The options expire on January 1, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The acquisition of stock options by the CEO aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with the long-term performance of the company.

Comparison to Industry Standards

• Stock option grants are a standard practice for executive compensation in the biotech industry.
• The vesting schedule of 25% after one year and the remainder over three years is typical for such grants.
• The exercise price of $0.77 is specific to Equillium's stock price at the time of the grant.

Stakeholder Impact

• The stock option grant aligns the CEO's interests with those of shareholders, potentially leading to increased focus on long-term value creation.

Key Dates

Keywords

stock options, insider trading, executive compensation, equity, Equillium, Bruce D. Steel